The Josep Carreras Institute creates a spin-off to develop therapies for leukaemia based on CAR–T

by Invivo Capital

The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya's (Government of Catalonia) CERCA network, has created the OneChain Immunotherapeutics (OCI)...

Read more

Telum Therapeutics raises € 4.1 million in its first round, led by Invivo Ventures, together with the co-investment of Clave Capital and CDTI-Innvierte

by Telum Therapeutics

Telum Therapeutics (‘Telum’), an emerging biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages, called enzybiotics, has ...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

A CNIC team creates a dynamic 3D atlas o...

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

Scientists at the Centro Nacional de Investigaciones Cardiovasculares ...

Photos Stream